Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00237120
Status:
COMPLETED
Last Update Posted:
2009-11-23
First Post:
2005-10-07
Brief Title:
Efficacy Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia Chronic Phase
Sponsor:
Organization:
Novartis